San Diego, CA, United States of America

Sandra R Slivka


Average Co-Inventor Count = 4.5

ph-index = 4

Forward Citations = 279(Granted Patents)


Company Filing History:


Years Active: 1995-2003

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of Sandra R. Slivka

Introduction

Sandra R. Slivka is a notable inventor based in San Diego, CA. She has made significant contributions to the field of medical treatments, particularly in addressing sexual dysfunction. With a total of 4 patents, her work has garnered attention for its innovative approaches.

Latest Patents

Among her latest patents is a method for treating erectile dysfunction using isoquinoline compound melanocortin receptor ligands. This patent outlines methods for treating erectile dysfunction with tetrahydroisoquinoline aromatic amines that function as melanocortin receptor ligands. Another significant patent focuses on melanocortin receptor-3 ligands to treat sexual dysfunction. This invention provides methods for treating conditions such as erectile dysfunction or sexual arousal disorder using specific compounds, including HP-228. These methods also allow for the screening of compound libraries for ligands that can treat MC-3-associated conditions.

Career Highlights

Throughout her career, Sandra has worked with various companies, including Lion Bioscience AG and Advanced Tissue Sciences, Inc. Her experience in these organizations has contributed to her expertise in the field of medical innovations.

Collaborations

Sandra has collaborated with notable individuals such as Beverly E. Girten and Timothy Gahman. These partnerships have further enhanced her research and development efforts.

Conclusion

Sandra R. Slivka's contributions to the field of medical treatments, particularly in sexual dysfunction, highlight her innovative spirit and dedication to improving health outcomes. Her patents reflect a commitment to advancing medical science through her inventive approaches.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…